Although non-coronary artery bypass graft ( CABG ) TIMI major bleeding was increased with prasugrel as compared with clopidogrel ( HR 1.40 , 95 % CI 1.05-1 .88 , p = 0.02 ) , there was a net clinical benefit in patients assigned to prasugrel ( HR 0.89 , 95 % CI 0.80-1 .00 , p = 0.043 ) , which was consistent for UA and NSTEMI subgroups ( interaction p value = 0.84 and 0.72 ) .